Story perspectives

Breakthrough Study Links SMARCAL1 Gene to Pediatric Osteosarcoma

10/10/2025

32 3

Summary

Story summary

Cleveland Clinic Children’s researchers identify SMARCAL1 as a key risk factor for pediatric osteosarcoma.
The study analyzed genetic data from nearly 6,000 cancer patients and over 14,000 cancer-free adults, reflecting collaborative research.
About 2.6% of children with osteosarcoma carry inherited SMARCAL1 mutations, potentially impairing DNA repair.
Finding could enable earlier detection and targeted therapies, addressing four decades of limited progress.

1 of 1

Story summary

Cleveland Clinic Children’s researchers identify SMARCAL1 as a key risk factor for pediatric osteosarcoma.
The study analyzed genetic data from nearly 6,000 cancer patients and over 14,000 cancer-free adults, reflecting collaborative research.
About 2.6% of children with osteosarcoma carry inherited SMARCAL1 mutations, potentially impairing DNA repair.
Finding could enable earlier detection and targeted therapies, addressing four decades of limited progress.